Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:03 PM
Ignite Modification Date:
2025-12-24 @ 11:03 PM
NCT ID:
NCT03684369
Eligibility Criteria:
Inclusion Criteria:
* Able to read, write, and speak English to ensure safe participation in the project
* Clinical diagnosis of multiple sclerosis
* Mild-to-moderate level of disability
* On stable doses of symptom-treating medications
* No MS exacerbations within the last 30 day
* Healthy enough to complete the protocol as indicated by the absence of a medical diagnosis or condition that is considered to be an absolute or relative contraindication to participating in tests that involve electrical nerve stimulation (e.g., not implanted devices or internal metal)
* Able to arrange own transportation to Boulder campus
Exclusion Criteria:
* Documented MS-related relapse within the last 30 days
* Medical diagnosis or condition that is considered to be a contraindication to participating in the intervention, such as major renal, pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (other than basal cell cancer), other neurological disorders, or pregnancy.
* Vestibular disorder
* Musculoskeletal disorder
* History of seizure disorders
* \>2 alcoholic drinks/day,or present history (last 6 months) of drug abuse
* Spasticity that requires the individual to change an activity more than once a week
* Skin disease or sensation problems in the legs or hands that influence some activities more than once a week
* Claustrophobia
* Metallic implants
* Inability to attend treatment sessions 3 days per week for 6 weeks
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT03684369
Study Brief:
Protocol Section:
NCT03684369